Deal Process & Mechanics interview questions

In a share sale the buyer acquires the company and everything in it, known and unknown, including its history. In an asset sale the buyer acquires identified assets and assumes identified liabilities, and everything else stays with the seller.

Sellers almost always prefer a share sale. It is a clean break: the liabilities go with the company, and in many jurisdictions the tax treatment on a share disposal is materially better than on an asset disposal followed by a distribution, which can be taxed twice.

Buyers often prefer an asset sale where they can get it. They take only what they want, leave historical tax, litigation, environmental and employment exposure behind, and in many jurisdictions get a step-up in the tax base of the assets acquired, which produces deductible depreciation and amortisation and is worth real money.

In practice, share sales dominate for whole companies in Europe, because the seller usually has the leverage and because employee transfer rules mean an asset sale does not escape employment liability anyway. Asset sales are the norm for carve-outs of a business line that is not in its own legal entity, and in distressed situations where the buyer specifically wants to leave the liabilities behind.

Restructuring the target group before completion so the perimeter matches what is being sold: moving a business line into a new entity, transferring assets out that are not part of the deal, settling intercompany balances, extracting real estate the seller is keeping, or separating a shared function.

It creates risk on several fronts. Tax, because a transfer at other than market value or without the right relief can crystallise a charge, and any degrouping charge usually lands on the buyer's new group. Contracts, because assignment often needs a counterparty consent that may not be given or may be used as leverage. Employees, because transfers engage TUPE in the UK and section 613a in Germany, with information and consultation obligations and a right to object. Licences and permits, which frequently cannot be transferred at all and have to be reapplied for. And operational separation, where shared IT, treasury and procurement mean the business cannot actually stand alone on day one, which is why transitional services agreements exist.

For the buyer the practical points are: get the steps plan and the tax opinion, make the reorganisation a condition, warrant that it has been completed as described, and negotiate the TSA scope and duration early rather than as an afterthought.

It is the instruction to bidders: the deadline, the format, and exactly what an offer must contain to be considered. Typically the price and the basis on which it is expressed, the assumed cash-free debt-free and working capital treatment, the source and status of funding including any equity commitment and debt papers, the conditions to completion, the approvals required and their expected timing, the remaining diligence scope, the advisers engaged, and the internal approvals still outstanding.

It matters because it makes offers comparable. Without it a seller receives one bid quoting enterprise value and another quoting equity value, one fully funded and one subject to committee, one with a two-week confirmatory scope and one wanting eight. You cannot rank those, and a banker who presents them to a board as a league table is misleading the client.

It is also the seller's main lever on process discipline. Bidders who ignore the format are usually the ones who will be difficult later, and that is useful information at phase one.

A pitch book is designed to secure an advisory mandate for a transaction like an M&A deal or debt issuance. It begins with the bank's credentials and relevant transaction history to demonstrate expertise. Next, it outlines the client's strategic options, provides a detailed valuation, and presents potential acquisition targets or buyers. It concludes with a summary of recommendations and a proposed timeline for the transaction.

Preparation, six to ten weeks. Agree the equity story, prepare the information memorandum and the teaser, build the management presentation, run vendor due diligence, set up the data room, clean up the perimeter, and build the buyer list with the client.

Phase one. Teaser out to the approved list, NDAs signed, information memorandum released, process letter setting the deadline and the required content. Bidders receive limited information and submit non-binding indicative offers with a value range, funding, conditionality, approvals needed and their timetable.

Phase two. A shortlist, typically four to six, goes to management presentations, full data room access, vendor due diligence reports, expert sessions and site visits. The SPA is issued as a seller-friendly draft for mark-up. Bidders submit binding offers with a marked SPA, evidence of financing and a short conditions list.

Final. Negotiate with two or three in parallel for as long as possible, because that is where the tension is. Then grant exclusivity, confirmatory diligence, final SPA negotiation, signing, and then completion once conditions such as antitrust clearance are satisfied.

The whole design has one purpose: keep more than one credible bidder alive past the point where the price is fixed. Value leaks the moment that stops being true.

Confidentiality first. An auction means the teaser goes to thirty parties, several of them competitors, and the information memorandum goes to a dozen. Customers, suppliers and staff find out, competitors learn the cost base and the customer concentration, and if the process fails the business is damaged and the owner has to wait years to try again. For an owner whose whole net worth and reputation sit in one company, that asymmetry is real.

Speed and burden second. An auction consumes the management team for six months. In a founder business the management team is often three people who are also running the company, and the trading performance during the process is itself part of the price.

And fit. Where the owner cares about the buyer's plan for the business, the staff or the name, a process optimised purely for price is optimising for the wrong variable.

The cost is obvious: no competitive tension, so the seller relies on a credible threat to walk away and on the adviser's read of what the market would pay. That is why bilaterals work best with a well-prepared seller, a genuine walk-away alternative, and an adviser who has recent comparable evidence.

I would begin by clarifying the client's specific expansion goals, such as target geographies, products, or financial metrics. Next, I would evaluate their financial profile to determine whether organic growth, partnerships, or acquisitions make the most sense given their capital structure. Finally, I would add value by introducing management to strategic partners or targets, structuring the transactions, and managing the execution process to achieve the best outcome.

The ideal time to suggest this review is when the General Partners are preparing to raise their next fund. Limited Partners are often skeptical of committing new capital if the PE firm has substantial undeployed capital from previous funds. To address this, GPs want to demonstrate they have actively deployed prior capital, sometimes even making early investments during the fundraising period to showcase the new fund's strategy and secure commitments.

Investment banks are primarily divided into industry groups and product groups. Industry groups, such as Healthcare or Technology, focus on building client relationships and managing various deal types within a single sector. Product groups, such as M&A or Leveraged Finance, specialize in executing a specific transaction type across all industries.

I would present the trade-offs of both options, noting that an M&A sale offers a clean break and immediate liquidity but sacrifices future upside and control. Conversely, an IPO allows the company to retain control and participate in future growth, but the process is highly time-consuming and complex. The optimal choice depends on the management team's long-term commitment and the growth potential remaining in the business.

The headline is the least informative part. You compare on four axes.

Certainty. Is the funding committed, and what does it depend on? A sponsor with equity commitment letters and signed debt papers may well be more certain than a strategic that needs a board resolution and has never done a deal this size.

Conditionality and timetable. A strategic in the same market brings antitrust risk, possibly a Phase 2 review and a remedy negotiation, and foreign investment screening. That can be a year of hold-separate risk on a business the seller no longer controls. A sponsor usually clears quickly.

The price basis. What multiple, off what EBITDA, with which add-backs accepted, on what debt-like list, and how much is deferred, in escrow, in an earn-out or in vendor notes. Two bids at the same enterprise value can be twenty percent apart in cash at completion.

Non-price terms. Warranty package, W&I, employee and management arrangements, and for a founder seller often the future of the business and the name, which can genuinely outrank a few percent of price.

Companies select investment banks primarily based on long-term relationships, the banks' track records, and the strength of their pitches during competitive 'bake-off' meetings. Often, bankers advise companies informally for years before a transaction occurs. A bank's specific expertise, such as a reputation for achieving high valuation multiples in a particular sector, also heavily influences the selection process.

That the two numbers are not comparable until you have put them on the same basis, and then give the board a recommendation rather than a spreadsheet.

First, restate both on a cash-at-completion basis: same earnings measure, same add-backs accepted, same debt-like list, and the deferred elements, escrow, earn-out and vendor notes stripped out or discounted. A 5% headline gap frequently closes or reverses at that stage.

Second, price the deliverability difference. Probability-weight each: the strategic's antitrust risk and timetable against the sponsor's financing condition and the state of the debt market on the day. An expected value that accounts for a fifteen percent chance of a failed deal after nine months is a different number from the headline.

Third, put the non-price terms in front of them explicitly, because they are the board's decision and not the adviser's: warranty package, employee commitments, and whatever the shareholders care about beyond price.

Then recommend. Boards are entitled to a view from their adviser, and presenting three comparably-sized numbers without one is not neutrality, it is an abdication.

A report commissioned by the seller, prepared by an accounting firm on financial, and often separately on commercial, tax and legal matters, and made available to bidders during the process. It is usually addressed to the seller and later relied on by the buyer and its lenders under a reliance letter, which is what gives it value.

The seller pays for it for three reasons. It preserves competitive tension, because every bidder gets the same information at the same time and no single bidder can slow the process by running its own full scope. It surfaces problems early, when the seller can fix them or price them, rather than in week six of exclusivity when the only available move is a price chip. And it shortens the timetable, which matters because a process that drags loses bidders.

Buyers still do confirmatory work on the points that matter to them, and lenders will usually want their own scope. But a good VDD moves the process from the buyer discovering things to the seller having already answered them.

An audit answers whether the accounts are free from material misstatement under the relevant framework. A quality of earnings report answers a different question: how much of the reported earnings is recurring, cash-generating and likely to be there next year under a new owner.

What it typically finds: revenue recognised earlier than the cash or the risk transfer would justify; margin flattered by one-off pricing or a single large contract; costs that sit below EBITDA in the reported accounts but are genuinely operating; related-party arrangements at off-market terms, which is common in founder-owned businesses; owner remuneration and personal expenses run through the P&L; capitalised costs that are really opex; provisions released into earnings; and a proof of cash reconciling reported EBITDA to actual cash generation, which is usually the single most useful exhibit in the report.

It also sizes the debt-like items and builds the working capital analysis the peg is set from, which is why the same team usually does both.

A legitimate add-back has three properties: the cost is genuinely non-recurring, it can be evidenced from source documents rather than a management schedule, and the business demonstrably runs without it going forward. Redundancy costs from a completed restructuring, the fees of a one-off litigation now settled, the cost of a closed site, or an owner's salary above market where the buyer will not replicate it, all qualify.

A hopeful add-back fails one of those. The most common failures: run-rate synergies from actions not yet taken, in a business the buyer has not yet owned; a restructuring that recurs every year under a different name, at which point it is simply a cost of doing business; pro-forma annualisation of a contract signed in month eleven with no delivery history; costs of a growth initiative treated as exceptional while the associated revenue is left in; and 'COVID normalisation' or any other adjustment that removes a bad period without removing the good one.

The practical test is symmetry. If the adjustment only ever moves EBITDA in one direction, it is a negotiating position and not a normalisation.

Size it before reacting. What is the margin on that customer as opposed to the revenue share, how long has the relationship run, what is the history of renewal, is there a competitive tender coming, what is the switching cost for the customer, and is there a relationship at the customer that survives the seller's departure.

Then choose the instrument that matches the risk, and the point is that this is a structuring problem rather than a price problem. Options in rough order of preference: make renewal a condition precedent, which is cleanest if the timetable allows and the customer can be approached; put a specific indemnity with an escrow behind it, sized to the margin at risk; put part of the price in an earn-out contingent on the renewal, which also keeps the seller working on it; or take the price down by the risk-weighted value.

A flat price chip is the weakest of those because it converts a binary, resolvable risk into a negotiation about a number, and it usually leaves both sides feeling badly done by. What you should not do is discover it in exclusivity: this is exactly the sort of thing vendor due diligence exists to surface at phase one.

Mechanically, the buyer pays 3m less. The price adjusts one for one against the peg, because the buyer will have to put 3m of cash into the business to get working capital back to the level the peg said it needs.

Whether the buyer is made whole is a different question. If the shortfall is genuine seasonality and the peg was set on a full-year average, the adjustment is roughly fair: the buyer receives less working capital and less price, and the business will build back up over the cycle.

If the shortfall is engineered, the buyer is not made whole. Stretched payables have to be unwound, which costs more than the balance sheet gap suggests once supplier relationships are priced in, and starved inventory means lost sales the price adjustment does not compensate. That is why the trend analysis matters more than the arithmetic, and why the adjustment alone is a weak protection.

By managing the balance sheet down in the weeks before completion, so the actual level at completion is below the level that was averaged into the peg, and the buyer pays the difference.

The usual moves: chase receivables hard, offer early settlement discounts, stop paying suppliers so payables balloon, run inventory down and do not reorder, factor receivables just before completion, and delay capex so the cash shows up as a lower working capital need than it really is. Every one of them makes completion working capital look lean and leaves the buyer to fund the normalisation afterwards.

You catch it by looking at the monthly trend rather than the completion balance alone. Days sales outstanding, days payable and inventory days plotted over twenty-four months make an engineered final month obvious: the ratios break trend in exactly the period after the process started. Ageing profiles of receivables and payables show the same thing. And you build defences into the SPA: a conduct-of-business covenant requiring ordinary course working capital management, a definition that captures factoring, and sometimes a separate check on the supplier ageing at completion.

Start at enterprise value, agreed as a multiple of a normalised earnings measure. Then:

Less financial debt. Not just the bank facilities: bonds, shareholder loans, finance leases, and anything else that is genuinely borrowing.

Plus cash, but only cash that is actually free. Trapped cash in a jurisdiction you cannot repatriate without tax, cash that is really a customer deposit, and the minimum operating cash the business needs to run on Monday morning are all excluded by a buyer who is paying attention.

Plus or minus the working capital adjustment against the agreed peg.

Less debt-like items. This is where the negotiation lives: unfunded pension deficits, deferred and contingent consideration from the target's own past acquisitions, factoring and reverse factoring, restructuring provisions, unpaid capex committed but not spent, dilapidations, tax liabilities crystallising on the deal, and the seller's transaction costs.

That gives equity value. Then deduct anything held back: escrow, retention against a specific risk, deferred consideration, vendor loan notes and the value of any rollover. What is left is the cash at completion, which is the only number the seller actually cares about.

It means the price is agreed for the business itself, on the assumption the seller strips out all cash and settles all debt at completion. In practice nobody does that literally; the adjustment is made in the price.

The argument is never about the bank loan or the current account balance. It is about the grey zone. The seller says everything on the balance sheet that is not a bank borrowing is working capital or a provision. The buyer says a list of items behave like debt because they are obligations to pay cash for something already consumed: an unfunded pension deficit, deferred consideration from an earlier bolt-on, a factoring facility that is funding rather than a receivable sale, accrued but unpaid bonuses, deferred capex on an asset that must be replaced, an onerous lease provision, and any tax that crystallises on the transaction.

Whoever writes the definition of debt-like items in the SPA wins those points. That is why the list gets negotiated line by line and why financial due diligence spends most of its time on it.

It is interest on the fixed equity price, running from the locked box date to completion, to compensate the seller for the fact that the buyer takes the economics of the business from the earlier date while paying later.

Two ways to set it. A cash-profit ticker approximates the cash the business actually generates in the gap, so the seller receives the value it created while still running the company. A simple interest ticker is a negotiated rate on the equity price, often somewhere near the buyer's cost of debt or a benchmark rate plus a margin, accrued daily.

The negotiation is really about who benefits from a long gap. A ticker set above the actual cash generation gives the seller an incentive to let completion drift; set below, the buyer gains from delay. Where the gap is long and uncertain, for instance because of a lengthy antitrust review, the ticker is one of the more valuable points in the whole SPA.

Completion accounts, in almost every case. A locked box needs a reliable, standalone balance sheet at the locked box date that the buyer can price off. A carve-out business does not have one: it has never been separately audited, its working capital has been managed as part of a group treasury, intercompany balances have to be unwound, and shared costs have to be allocated on assumptions the buyer has no way to verify from outside.

So the buyer will not accept a fixed price off accounts that are effectively a management construction. Completion accounts let it measure what it actually got, on a defined accounting policy hierarchy, once it controls the business.

The counter-case is a sponsor exit of a clean standalone company with audited accounts and a short, predictable gap to completion. There a locked box is faster, cheaper and gives both sides certainty.

Leakage is value passing from the target to the seller or its connected persons between the locked box date and completion, in a way that was not reflected in the fixed price. The classic list: dividends and distributions, management fees or monitoring fees to the sponsor, bonuses paid in connection with the transaction, waivers of amounts owed by the seller, assets transferred out at less than value, and the seller's own transaction costs pushed into the target.

The seller gives a covenant, usually an indemnity on a euro-for-euro basis with no basket and no cap other than the price, that no leakage has occurred. That indemnity typically survives for six to twelve months after completion, which is far shorter than the warranty period, because leakage is a matter of fact rather than of judgement.

Permitted leakage is the agreed carve-out list: ordinary course salaries, contractual management fees at existing levels, an agreed pre-completion dividend, and anything else the parties price in. It is negotiated line by line and it belongs in a schedule, not in a general concept, because anything not listed is by definition a claim.

You are trying to answer one question: what level of working capital does the buyer need to be handed so the business can run the day after completion without the buyer having to inject cash?

The standard method is a trailing average, usually twelve monthly balance sheet positions, sometimes twenty-four where the business is volatile. Twelve months is used because it captures a full seasonal cycle, which a spot balance sheet does not.

Then you normalise. Strip out anything that is being counted as debt or cash so it is not double counted. Adjust for one-off items: a large one-time order, a stock build for a product launch, a receivable that is really a dispute. Adjust for known structural change: if payment terms with the largest customer changed six months ago, the older months are not representative and the average has to be recalculated on the new terms. And check consistency of accounting policy across the period, because a change in cut-off or provisioning moves the average without anything economic having happened.

The output is a target, and the price moves one for one with the difference between the actual level at completion and that target.

They are two ways of fixing the price, and they differ in when the business is frozen economically and who carries the risk between signing and completion.

Completion accounts: the parties agree a headline enterprise value and an estimated cash, debt and working capital position at signing. After completion, accounts are drawn up as at the completion date, the actual cash, debt and working capital are measured, and the price is trued up in a post-closing payment either way. The buyer pays for what it actually receives, but the price stays open and contestable for months afterwards.

Locked box: equity value is fixed by reference to a set of historical accounts at an agreed locked box date, usually the last audited or reviewed balance sheet. From that date the economic risk and reward of the business sit with the buyer, even though the seller still operates it. There is no post-completion adjustment. The buyer is protected instead by a covenant against leakage, and usually compensated for the delay by an equity ticker.

Europe, and European sponsor exits in particular, lean heavily to locked box: it gives the seller price certainty and a clean break, and it removes the single most common source of post-closing dispute.

At signing the parties are contractually bound on agreed terms. At completion the shares transfer and the money moves. The gap exists because things have to happen that cannot happen before there is a binding deal.

What sits in between: antitrust clearance, foreign investment screening, other regulatory approvals, works council information and consultation in Germany and elsewhere, third-party consents such as change-of-control clauses in key contracts, financing drawdown, and any agreed pre-completion reorganisation of the perimeter.

The gap is where the risk allocation in the SPA does its work. The conditions precedent say what must happen; the conduct-of-business covenants constrain what the seller may do while it still runs a business the buyer has bought; the long-stop date says when either side can walk; any material adverse change clause says whether a deterioration lets the buyer out; and the completion mechanism, locked box or completion accounts, decides who carries the economics of the gap.

For a simple private deal signing and completion can be simultaneous, and then most of that machinery is unnecessary.

You use an earn-out when the two sides cannot agree on the value of the future rather than the past: a founder who believes a pipeline will convert, a business whose growth is real but unproven, or a target where a single contract renewal swings the value. The earn-out defers part of the price and makes it contingent on that future being delivered, which bridges the gap without either side conceding the argument.

EBITDA is a poor trigger because it is the line the buyer controls most easily after completion. Once the buyer owns the business it can allocate group overhead into it, push through management charges, change transfer pricing, redirect a sale to a sister company, invest in headcount that depresses near-term earnings, or simply change accounting policy. None of that is necessarily bad faith; it is ordinary integration. But every one of those moves reduces the earn-out, and the seller has no control and often no visibility.

So earn-outs are better hung on something the buyer cannot easily move: revenue, gross profit, units shipped, contracts renewed, a regulatory approval received. And whatever the metric, the SPA needs protective covenants for the earn-out period, a stated accounting basis, information rights, and a dispute mechanism. Earn-outs generate more litigation per euro than any other term in the agreement.

Warranty and indemnity insurance transfers the risk of a warranty breach from the seller to an insurer. The buyer takes out a buy-side policy, the warranties are given by the seller but recourse for breach runs to the insurer rather than to the seller, and the seller's liability is capped at a nominal amount, often one euro.

It became standard because it solves the sponsor's problem exactly. A fund exiting wants to distribute proceeds and close the fund; it cannot leave a warranty tail open for two years, and it will not give a meaningful cap. Before W&I that meant either an escrow, which traps money, or a buyer accepting almost no recourse. Insurance gives the buyer a real counterparty and the seller a clean break at a cost of roughly one percent of the insured limit, which on a competitive auction is cheap relative to what the seller saves.

What it does not cover matters. Known issues found in diligence are excluded, as are forward-looking statements, pension underfunding, transfer pricing and secondary tax liabilities in many policies, and anything the buyer failed to diligence. The exclusions are why insurers require evidence of a proper diligence process before underwriting, and why W&I raises the standard of diligence rather than lowering it.

A condition allowing the buyer to walk away between signing and completion if something sufficiently bad happens to the target. In practice it almost never works, and both sides know that when they negotiate it.

It fails for two reasons. The drafting is heavily carved out: general economic conditions, industry-wide conditions, market movements, changes in law and accounting, and anything disclosed or foreseeable are excluded, so what remains is usually a target-specific catastrophe. And the threshold as courts have interpreted it is very high, requiring durational significance rather than a bad quarter, so a buyer with second thoughts about the price has no case.

Its real function is not to be exercised. It is a negotiating position for the period between signing and completion, and its existence changes behaviour without ever being invoked. Sellers in strong markets, especially funds, resist a MAC entirely or accept only a narrow, quantified, target-specific trigger.

A buyer that genuinely wants protection against deterioration is better served by a short gap, specific conditions on identified risks, or price structure such as an earn-out.

Money held back from the price by a third party for a defined period, released to the seller if no claim arises and to the buyer if one does. It is the pre-insurance answer to warranty risk and it has not gone away.

You use it where W&I will not respond. A known issue found in diligence is excluded from the policy by definition, so a specific indemnity backed by a specific escrow is the only way to cover it: an open tax audit, live litigation, an environmental liability at a named site, a contract consent that has not been obtained. You also use it where the counterparty risk is real, for instance a private seller in a jurisdiction where enforcement is slow, and where a completion accounts true-up could run against a seller who has already distributed the proceeds.

The cost is that the money is trapped, which is exactly what a fund seller is trying to avoid, so the size and duration are negotiated hard and it is usually reserved for identified risks rather than general warranty cover.

To align incentives. A management team that has taken its whole stake in cash at completion has no economic reason to work through five hard years; a team with meaningful money in the new structure does. The sponsor also reads the rollover as a signal: a team that will not put its own proceeds back in is telling you something about its own view of the plan.

The typical ask is that management rolls a material proportion of its net proceeds, commonly a third to a half, and the sponsor cares much more about the proportion of what they personally have than about the absolute number or the percentage of the cap table.

The rollover usually goes into the same instrument mix as the sponsor, or into sweet equity: ordinary shares alongside a much larger loan note or preference strip held mostly by the sponsor. That structure is what gives management a levered return, because the preference instrument is repaid first and the ordinary equity takes the residual. It is also why a modest change in exit value swings the management outcome so violently, and why the ratchet and the leaver provisions get negotiated as hard as the price.

A binding undertaking not to talk to anyone else for a defined period, usually four to eight weeks, granted to one bidder so it will spend real money on confirmatory diligence and financing.

What the seller gives up is all of its leverage at once. Until exclusivity the seller has alternatives and the bidder knows it; after it, the bidder is the only buyer in the room and any issue it finds becomes a negotiation the seller can only lose. The classic outcome is the late price chip: at week five, with the other bidders gone cold, the buyer reports a diligence finding and reduces the price, and the seller's realistic options are to accept or to restart a process that is now visibly damaged.

Defences: keep exclusivity short and make extension conditional; require the buyer to confirm price and terms in writing before it starts; narrow the confirmatory scope to defined workstreams rather than open diligence; keep the underbidder warm even though you cannot negotiate; and try to sign the SPA on agreed terms with only the confirmatory conditions outstanding.

The document in which the seller discloses against the warranties. A warranty is a statement of fact; the disclosure letter says where that statement is not true, and a properly disclosed matter cannot found a claim.

It matters because it is where the warranty package is actually set. A seller can accept a long list of buyer-friendly warranties and then disclose them into irrelevance, and a buyer that negotiated hard on the warranty schedule and did not read the disclosures has won nothing. It has two parts: general disclosures, which deem whole categories of material to be disclosed, including in some drafts the entire data room, and specific disclosures against numbered warranties.

The fights are over the data room sweeper, which a buyer resists because it converts a warranty into a duty to have read forty thousand documents, and over the standard of disclosure, typically 'fair disclosure with sufficient detail to identify the nature and scope of the matter' rather than mere mention. Under W&I the insurer takes the same view, which is why disclosure quality is underwritten.

Deferred consideration documented as a loan from the seller to the buyer, sitting in the buyer's capital structure, usually deeply subordinated to the acquisition debt, often with PIK interest and a bullet repayment after the senior debt.

The buyer likes it because it is funding it did not have to raise: it reduces the equity cheque and the amount of third-party debt, and it does not have to be serviced in cash. The seller accepts it for one of three reasons. It is the only way to get the headline price it wanted, because the buyer could not fund the whole number. It signals confidence in the business, which matters where the seller is staying involved. Or the tax treatment of deferred consideration is better than cash today in that jurisdiction.

The risk is entirely the seller's: it is now an unsecured, subordinated creditor of a leveraged buyer, ranking behind the banks, with no control and often no security. If the business underperforms, the note is the first thing that does not get paid. Sellers who understand that negotiate for security, a shorter tenor, cash interest, or a higher headline price to compensate.

Under Rule 2.6 of the Takeover Code, once a potential bidder is publicly named in a possible offer situation, it has 28 days to either announce a firm intention to make an offer under Rule 2.7 or announce that it will not bid. If it does the latter, it is normally restricted from bidding again for six months.

It exists because a named but uncommitted bidder is corrosive: the target's shares trade on speculation, management is distracted, customers and staff are unsettled, and the bidder has a free option to keep looking while the target absorbs the cost.

A target uses it as a defence by simply letting the clock run, or by declining to extend. The deadline can be extended only with the target board's consent and the Panel's agreement, so the board holds the pen. A board that wants to force a low-balling bidder either to commit at a credible price or to go away just refuses the extension. Conversely a board that is negotiating seriously will extend to allow diligence and financing to finish.

That makes the extension request itself a negotiating event, and one of the few points of leverage a target board has in the pre-announcement phase.

Certain funds is the standard the Takeover Code imposes through the cash confirmation requirement: at Rule 2.7 the bidder's adviser must publicly confirm that resources are available, so the financing must be effectively unconditional at announcement.

In practice that means the facility agreement is signed before the announcement, and during the certain funds period the lenders' ability to refuse to fund is cut back to a very short list of major defaults: typically insolvency of the bidder, illegality, and breach of a small set of fundamental representations. Market MAC clauses, general material adverse change, a broad conditions list and market flex on economics that could prevent funding are all disapplied for the period.

A US commitment letter is a different instrument. It is a commitment to provide financing subject to conditions, and it usually retains market flex, a SunGard-style limited conditionality construct rather than the Code's public confirmation, and an out if the syndication market moves.

The practical consequence for a bidder is that everything moves earlier. Diligence, credit approval and full documentation have to be finished before the announcement rather than afterwards, which is why UK public deals have a long, quiet pre-announcement phase and then move very fast once 2.7 goes out.

Rule 21 of the Takeover Code prohibits the target board, once an offer is imminent or has been made, from taking any action that could frustrate the offer without shareholder approval in general meeting. That covers issuing shares, granting options, disposing of material assets, entering into contracts outside the ordinary course, and anything else that would make the target less attractive.

The difference from the US is fundamental. A Delaware board can adopt a poison pill unilaterally and use it to block a hostile bidder more or less indefinitely, subject to fiduciary review, which is why hostile deals in the US are fought at the board and in court. In the UK the decision belongs to shareholders and the board cannot take it away from them. There are no poison pills, no staggered boards used defensively, and no just-say-no defence.

What a UK board can actually do is argue: reject the offer as undervaluing the company, publish a defence document with new information or upgraded guidance, find a white knight, lobby on public interest grounds, and run the PUSU clock. The defence is persuasion, not obstruction, and that shapes the entire strategy from day one.

The announcement of a firm intention to make an offer under the UK Takeover Code. Before it, a bidder is in a possible offer situation and can walk away. After it, it is committed.

What it triggers. The bidder must proceed on the announced terms and post the offer document or scheme circular within 28 days. It can only invoke a condition to walk away where the Panel agrees the circumstances are of material significance, which is an extremely high bar in practice, so for most purposes the announced price is binding. The formal timetable starts. And the announcement itself must contain the terms, the conditions, details of any irrevocables, and a statement of the bidder's intentions for the target's business, employees and pension schemes, which is now enforceable as a post-offer undertaking.

Crucially, the bidder's financial adviser must give a cash confirmation: a public statement that the bidder has sufficient resources to satisfy full acceptance. That is not a formality. The adviser is on the hook, and the Panel has required advisers to fund shortfalls. It is why the financing has to be certain funds before 2.7, and why UK acquisition financing looks different from a US commitment paper with wide conditionality.

A commitment from a target shareholder to accept the offer or vote for the scheme. A bidder collects them before announcement, typically from directors and large institutions, to de-risk the deal and to signal support.

Hard irrevocable: binds the shareholder regardless of what happens, including a higher competing offer. Institutions almost never give these because their fiduciary duty makes locking out a better price difficult, so they are largely confined to directors and to shareholders with a strategic reason.

Soft irrevocable: falls away if a competing offer is announced above a stated threshold, often a specified percentage above the original price. This is the common institutional form.

Irrevocable with a matching right: falls away on a higher competing offer, but only if the original bidder does not match within a defined short period. It sits between the two and is increasingly the negotiated middle ground.

There is also the letter of intent, which is a non-binding statement of support and worth correspondingly less, though it must still be disclosed. What matters commercially is the aggregate percentage locked up and how hard it is: 30% of hard irrevocables is a serious deterrent to an interloper, while 30% of soft ones deters nobody.

Under Rule 9 of the Takeover Code, a person who acquires an interest in shares carrying 30% or more of the voting rights of a Code company, or who already holds between 30% and 50% and acquires any further interest, must make a cash offer for all the remaining shares.

The price is not negotiable: it must be at least the highest price the bidder or anyone acting in concert with it paid in the preceding twelve months, and it must be in cash or with a cash alternative. The offer can only be conditional on receiving acceptances taking the bidder above 50%, so almost none of the usual bidder protections are available.

The logic is that control has changed hands and minority shareholders are entitled to exit at the price control was bought at. Thirty percent is the threshold because that is where practical control of a listed UK company usually sits, well below an absolute majority.

The concert party analysis is where this gets dangerous in practice: shareholders acting together, a bidder plus its financing partners, or a management team rolling over alongside a sponsor can be aggregated without anyone intending it. Where a transaction would otherwise trigger Rule 9, the Panel can grant a whitewash waiver, approved by a vote of independent shareholders.

A scheme is a court-sanctioned statutory procedure run by the target; a contractual offer is a direct offer by the bidder to shareholders. On a recommended deal the scheme is now the default in the UK.

The reason is the threshold and the outcome. A scheme needs a majority in number of the shareholders voting, representing at least 75% in value, at a court-convened meeting, plus a special resolution and then court sanction. If it passes, it binds 100% of the shareholders automatically, on the day the court order is registered. There is no rump and no minority.

A contractual offer needs 90% acceptances of the shares to which the offer relates before the bidder can compulsorily acquire the rest under the squeeze-out. Below that the bidder is left with a minority on the register, which is unacceptable if the acquisition is debt-funded, because the lenders want the target's assets and cash flow available for security and upstreaming.

The bidder also saves stamp duty on a scheme, which on a large deal is 0.5% of consideration and a real number.

The critical limitation: a scheme is run by the target board, which controls the timetable and can pull it. So a scheme is impossible for a hostile bid, and a bidder that fears the recommendation may be withdrawn will want the right to switch to an offer.

A Beherrschungs- und Gewinnabfuhrungsvertrag, usually called a DPLTA. It is a corporate agreement between the bidder and the German target under which the bidder acquires the right to issue binding instructions to the target's management board, and the target transfers its entire profit to the bidder and the bidder covers its losses.

The bidder wants it because without it a German AG is remarkably independent even of a majority shareholder. The management board runs the company on its own responsibility under section 76 AktG, and a controlling shareholder cannot simply direct it. More practically, without a DPLTA the bidder cannot upstream the target's cash freely or pool it in group treasury, and cannot use the target's cash flow to service acquisition debt. For a leveraged buyer that is decisive.

It requires a 75% majority of the share capital represented at the target's general meeting, and it is registered in the commercial register.

The price is that it triggers statutory protections for the remaining minority: a guaranteed annual compensation payment, the Ausgleich, and a right for minorities to have their shares bought out at an adequate cash settlement, the Abfindung. Both are open to challenge in an appraisal proceeding, the Spruchverfahren, which can run for years and can increase the amount retroactively. That open-ended liability is the reason a bidder budgets for a DPLTA rather than treating it as a formality.

They add obligations that are conditions in practice even where they are not conditions in the SPA, and they change when you are allowed to tell people.

The Betriebsrat, the works council, has information and consultation rights under the Betriebsverfassungsgesetz. On a share deal the obligation is comparatively light, but on an asset deal or a carve-out the transfer engages section 613a BGB: employees must be informed in writing of the transfer, the reason, the legal, economic and social consequences and the measures envisaged, and each employee has a one-month right to object to the transfer of their contract. An employee who objects stays with the seller, which can be exactly the wrong employee.

Where the transaction involves an operational change, a Betriebsanderung, the employer must negotiate a reconciliation of interests and a social plan with the works council before implementing it. That is a real negotiation with a real timetable and it cannot be short-circuited.

On top of that, co-determination puts employee representatives on the supervisory board, half of it in companies above two thousand employees under the Mitbestimmungsgesetz, so the board that approves the transaction includes the counterparties to the consultation.

The practical consequences for a banker: build consultation into the timetable rather than treating it as a post-signing formality, expect the announcement date to be driven partly by when the works council can be informed, and be careful with confidentiality, because the number of people who must be told before completion is larger than in the UK.

There are three squeeze-out routes and which one is available depends on the stake reached.

At 95% of the share capital, the corporate squeeze-out under sections 327a to 327f AktG: a general meeting resolution transfers the minority shares against an adequate cash settlement, valued by a court-appointed auditor. It is the most common route and the settlement is open to challenge in a Spruchverfahren.

At 95%, the merger squeeze-out under the UmwG, available where the bidder is an AG and a merger of the target into it is being effected. It is faster and the valuation basis is somewhat different.

At 95% of the shares to which a takeover offer related, and only within three months of the end of the acceptance period, the takeover squeeze-out under the WpUG. This one is attractive because the consideration offered in the takeover is presumed adequate where 90% or more of the shares covered by the offer were tendered, which largely closes off the appraisal challenge.

The practical sequence for a bidder is therefore: run the offer, aim to clear 95% within the offer window and use the WpUG squeeze-out, because it is the only route that materially limits appraisal risk. Failing that, put a DPLTA in place at 75% to get control of cash flow, accumulate to 95% in the market over time, and then run the corporate squeeze-out. That second path can take years and carries the Spruchverfahren tail, which is why German public deals so often leave a minority in place for longer than a UK deal would.

The GmbH is the private limited company: the standard vehicle for Mittelstand businesses, requiring a minimum share capital of twenty-five thousand euros, managed by one or more Geschaftsfuhrer who are bound by shareholder instructions, with a supervisory board only where co-determination thresholds require one. Shares are not securities and are not freely transferable in a market.

The AG is the stock corporation: minimum share capital of fifty thousand euros, mandatory two-tier board with a Vorstand that manages on its own responsibility under section 76 AktG and an Aufsichtsrat that appoints and supervises it, and shares that are securities capable of being listed.

The transaction consequences are practical. Governance: a GmbH's managing directors take instructions from the shareholders, so a majority buyer controls the business directly, whereas an AG's management board does not, which is why controlling an AG requires the domination agreement discussed elsewhere. Transfer formality: a transfer of GmbH shares must be notarised by a German notary, which is a real logistical step on a signing, and it is one reason German closings are choreographed around a notary's diary. And flexibility: a GmbH's articles can be shaped far more freely, whereas the AktG is largely mandatory law, which is why sponsors frequently convert an AG target into a GmbH or a GmbH & Co. KG after acquisition.

The GmbH & Co. KG is worth knowing too: a limited partnership whose general partner is a GmbH, combining limited liability with partnership tax transparency, and extremely common in family-owned German businesses.

The Wertpapiererwerbs- und Ubernahmegesetz, the WpUG, supervised by BaFin rather than by a practitioner panel. It applies to offers for companies whose voting shares are admitted to trading on a regulated market in the EEA with a German seat.

The mandatory offer threshold is 30% of voting rights, the same headline number as the UK, and crossing it obliges a Pflichtangebot to all remaining shareholders.

The minimum price rule is the part that differs in mechanics and is easy to get wrong. The offer price must be at least the higher of two things: the highest consideration the bidder or a person acting jointly with it paid or agreed to pay for target shares in the six months before the announcement, and the volume-weighted average domestic stock exchange price of the target's shares over the three months before the announcement. That three-month VWAP floor is not in the UK regime and it matters: a bidder acting after a share price run cannot price off the current market, and a bidder acting after a collapse cannot buy at the trough.

The other structural difference is the enforcement style. BaFin is a regulator applying a statute with legal remedies; the UK Panel is a practitioner body ruling in real time on principles. The German process is more formal and more litigable, and post-offer squeeze-out and price challenges in the German courts are a routine feature rather than an exception.

Chapter 7 bankruptcy is a liquidation process where a company is past saving, requiring a court-appointed trustee to sell off its assets to repay creditors. In contrast, Chapter 11 is a reorganization process where the company continues to operate while restructuring its debt. Under Chapter 11, the company renegotiates its liabilities or executes a debt-for-equity swap to repay creditors over time.

Debtor-in-possession (DIP) financing is specialized funding raised by a bankrupt company that holds repayment priority over all existing debt and equity claims. Distressed companies use DIP financing to maintain operations and facilitate their emergence from Chapter 11 bankruptcy. While it provides essential liquidity, some lenders use DIP terms to aggressively position themselves for a discounted takeover of the company's assets.

A company can become stressed due to macro factors like industry downturns and economic shocks, or micro factors such as poor management decisions and excessive debt. To transition from stressed to distressed, a specific catalyst is required. This catalyst is typically a missed interest payment, a covenant violation, a credit rating downgrade, or cash falling below a critical threshold.

Stressed companies can still meet their interest obligations but face an impending cash crunch or upcoming debt maturity. Distressed companies have officially defaulted by missing a payment, failing to address a maturity, or violating a financial covenant. Bankrupt companies have already entered legal proceedings under Chapter 7 or Chapter 11 to resolve their debts.

Restructuring deals involve two primary sides: the debtor (the troubled company) and the creditors (the lenders). Advising the debtor is comparable to sell-side M&A, where you help the company find a resolution, while advising creditors is similar to buy-side M&A, focusing on maximizing asset recovery. Although most restructuring groups advise both sides, individual investment banks often specialize in or favor one side over the other.

A distressed company has several options, starting with refinancing, which is non-disruptive but extremely difficult to execute due to investor risk aversion. It can also pursue an asset or company sale, which recovers some creditor value but usually at a heavily discounted price. Alternatively, the company can restructure its debt terms or execute a debt-for-equity swap, though getting all parties to agree is challenging. Finally, declaring bankruptcy offers a structured negotiation framework and access to new funding, but causes severe business disruption and typically wipes out common shareholders.